XPrecise (Beijing) Medical Technology Co., Ltd. (referred to as XPrecise), was established in Beijing on November 15th, 2022, as a large-scale manufacturer and service provider of medical radiotherapy equipment and systems. With a focus on the perfect integration of imaging and radiotherapy, XPrecise is an enterprise with advanced research and development capabilities in medical imaging and radiation therapy. The R&D team is composed of senior experts from well-known enterprises and institutions at home and abroad, with a technical staff comprising 80% professionals and over 30% graduate students. XPrecise has rich technical experience in the research and development of medical imaging and radiation therapy.
Radiotherapy technology has been developing for decades. Especially in recent years, medical imaging technology has made more and more contributions to the accuracy of radiotherapy. It is well known that traditional radiotherapy uses cone beam cone-beam computed tomography (CBCT) images for image guidance. However, CBCT is different from conventional CT in that its blurred and non-real-time image quality is difficult to meet the needs of the latest adaptive radiotherapy and other new clinical techniques. How to meet the clinical requirements for image quality has become a breakthrough in the development of radiotherapy equipment.
Xprecise integrates the diagnostic CT system and the latest volumetric modulated arc therapy accelerator, and develops coaxial and coplanar CT/linac medical accelerators with adaptive radiotherapy, which can not only significantly improve the image quality of guided radiotherapy, but also improve the accuracy of radiotherapy. At present, this product is in the world's leading level.
Nowadays, medical linear accelerators are in a period of development opportunities. Under the influence of such driving factors as the aging of society and the popularization of cancer early screening, import substitution promoted by medical insurance cost control and industrial chain reconstruction, the increase in the penetration rate of radiotherapy therapy, the liberalization of radiotherapy equipment configuration planning, and the increase in county market demand, the radiotherapy market size is expected to usher in rapid growth.
